Authors: | Hoimes, C. J.; Flaig, T. W.; Milowsky, M. I.; Friedlander, T. W.; Bilen, M. A.; Gupta, S.; Srinivas, S.; Merchan, J. R.; McKay, R. R.; Petrylak, D. P.; Sasse, C.; Moreno, B. H.; Yu, Y.; Carret, A. S.; Rosenberg, J. E. |
Article Title: | Enfortumab vedotin plus pembrolizumab in previously untreated advanced urothelial cancer |
Journal Title: | Journal of Clinical Oncology |
Volume: | 41 |
Issue: | 1 |
ISSN: | 0732-183X |
Publisher: | American Society of Clinical Oncology |
Date Published: | 2023-01-01 |
Start Page: | 22 |
End Page: | 31 |
Language: | English |
DOI: | 10.1200/jco.22.01643 |
PROVIDER: | EBSCOhost |
PROVIDER: | cinahl |
PUBMED: | 36041086 |
PMCID: | PMC10476837 |
DOI/URL: | |
Notes: | MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- MSK corresponding author is Jonathan Rosenberg -- Accession Number: 160929612 -- Entry Date: In Process -- Revision Date: 20221226 -- Publication Type: Article -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 8309333. -- Source: Cinahl |